GlassScriptPhysician profile
David R Gotham
NPI 1023009297
$3,658.33
in general payments reported to CMS, 2019-2025
24 companies · $421 in 2025
The $421 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,093 · 2020: $87.84 · 2021: $151 · 2022: $511 · 2023: $250 · 2024: $145 · 2025: $421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $816.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $816.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,948.21 | 2019 | |
| Zimmer Biomet Holdings, INC. | $410.49 | 2019-2025 | Avenir |
| Smith+Nephew, INC. | $233.41 | 2020-2025 | Renasys, Renasys Touch, Pico |
| Avanos Medical | $187.75 | 2022-2023 | On-Q* Pump and Accessories |
| Stryker Corporation | $108.29 | 2024-2025 | Orthomap, Triathlon |
| Depuy Synthes Sales INC. | $95.89 | 2019-2023 | Monovisc, Orthovisc |
| Ethicon US, LLC | $86.78 | 2020-2025 | Vistaseal |
| Mimedx Group, INC. | $80.42 | 2024-2025 | |
| Allergan, INC. | $78.90 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $60.25 | 2025 | |
| Fidia Pharma USA INC. | $46.97 | 2019-2025 | Hyalgan |
| Bioventus LLC | $45.98 | 2019-2020 | |
| Heraeus Medical, LLC. | $45.89 | 2023-2024 | Palacos |
| Pacira Therapeutics, INC. | $32.11 | 2019 | |
| Orthofix Medical, INC. | $30.90 | 2019-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $28.42 | 2024 | Arista Ah Flexitip |
| Pacira Pharmaceuticals Incorporated | $25.48 | 2023 | Zilretta, Iovera, Exparel |
| Evolution Surgical, INC | $21.45 | 2024 | |
| Moximed, INC | $21.28 | 2025 | Misha Knee System, Small, Left |
| Dynasplint Systems INC. | $16.48 | 2023 | Dynasplint |
| Baudax Bio INC. | $15.17 | 2020 | |
| Horizon Therapeutics Plc | $13.97 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $12.03 | 2022 | |
| Merz North America, INC. | $11.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Gotham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.